WEISS ANDREA
CIK: 0001247063
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Cracker Barrel (CBRL) Discussed in Earnings Estimate Upside and 90% Stock Gain. An article raised the question of whether Cracker Barrel could benefit from rising earnings estimates. Another piece noted the stock's 90% rise over the past six months. These reports highlight investor interest and the company's recent performance. The stock trades near its 52‑week high and has a 6.64% dividend yield.
Transaction History
| ORLY | ▼ Sell | Open Market | 248 | $325K | 2/24/2025 | View on chart |
| ORLY | ▼ Sell | Open Market | 600 | $734K | 11/22/2024 | View on chart |
| ORLY | ▲ Buy | Grant | 173 | $175K | 5/17/2024 | View on chart |
| ORLY | ▼ Sell | Open Market | 200 | $186K | 8/7/2023 | View on chart |
| ORLY | ▲ Buy | Grant | 169 | $161K | 5/19/2023 | View on chart |
| CBRL | ▲ Buy | Grant | 1,210 | $0 | 11/17/2022 | View on chart |
| ORLY | ▼ Sell | Open Market | 100 | $71K | 8/3/2022 | View on chart |
| ORLY | ▲ Buy | Grant | 248 | $158K | 5/13/2022 | View on chart |
| CBRL | ▲ Buy | Grant | 841 | $0 | 11/18/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
ORLY Faces Earnings Watch Amid Mixed Analyst Views
Investors are watching O'Reilly Automotive ahead of its next earnings report, with questions about whether it will beat estimates again. While some analysts view the stock as a high-quality compounder at a reasonable valuation, others suggest it may be overlooked. The company is currently trading within its 52-week range, with an average analyst target of $107.35.
ORLY Faces Earnings Watch Amid Mixed Analyst Views. Investors are watching O'Reilly Automotive ahead of its next earnings report, with questions about whether it will beat estimates again. While some analysts view the stock as a high-quality compounder at a reasonable valuation, others suggest it may be overlooked. The company is currently trading within its 52-week range, with an average analyst target of $107.35.